Maximizing SPECTRALIS in the Detection and Interpretation of Ocular Biomarkers

Andrew Rixon, OD, FAAO, Diplomate (Glaucoma) leads this complimentary webinar on the intricacies of ocular biomarkers, detection, and interpretation using OCT. Dr. Rixon empowers attendees to use cross-sectional OCT in detecting retinal biomarkers consistent with AMD, diabetes, and glaucoma and implementing their use prognostically, discusses how serial RNFL analysis can be beneficial in clinic to determine evolution of disease and helps participants evaluate the value of fundus autofluorescence and OCT angiography in retinal disease.